Evaluation of Macular Ganglion Cell-inner Plexiform Layer and Choroid in Psoriasis Patients Using Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography
dc.contributor.author | Ersan, Ismail | |
dc.contributor.author | Kilic, Sevilay | |
dc.contributor.author | Arikan, Sedat | |
dc.contributor.author | Kara, Selcuk | |
dc.contributor.author | Isik, Selda | |
dc.contributor.author | Gencer, Baran | |
dc.contributor.author | Ogretmen, Zerrin | |
dc.date.accessioned | 2025-01-27T21:02:07Z | |
dc.date.available | 2025-01-27T21:02:07Z | |
dc.date.issued | 2017 | |
dc.department | Çanakkale Onsekiz Mart Üniversitesi | |
dc.description.abstract | Purpose: To evaluate changes in the thickness of the central macula, macular ganglion cell-inner plexiform layer (mGCIPL), and subfoveal choroid in patients with psoriasis using spectral domain optical coherence tomography (SD-OCT). Methods: The measurements of macular, mGCIPL thicknesses and subfoveal choroidal thickness (SFCT) obtained by SD-OCT of psoriasis patients (n = 46). These measurements were compared with those of 50 healthy controls. Results: The macular, mGCIPL, and choroidal thicknesses did not differ between the controls and psoriatic subjects (p>0.05). When the patients were divided into two distinct groups, only the SFCT was significantly thicker in the severe psoriasis group compared with the mild psoriasis group (p = 0.003). Conclusions: These findings suggest that choroidal alterations are seen without macular changes in patients with psoriasis. Severe psoriasis appears to be related to increases in SFCT as a consequence of possible inflammatory cascades that are part of the disease's pathogenesis. | |
dc.identifier.doi | 10.3109/09273948.2016.1150493 | |
dc.identifier.endpage | 524 | |
dc.identifier.issn | 0927-3948 | |
dc.identifier.issn | 1744-5078 | |
dc.identifier.issue | 4 | |
dc.identifier.pmid | 27015161 | |
dc.identifier.scopus | 2-s2.0-84961658035 | |
dc.identifier.scopusquality | Q1 | |
dc.identifier.startpage | 520 | |
dc.identifier.uri | https://doi.org/10.3109/09273948.2016.1150493 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12428/27286 | |
dc.identifier.volume | 25 | |
dc.identifier.wos | WOS:000412790900011 | |
dc.identifier.wosquality | Q1 | |
dc.indekslendigikaynak | Web of Science | |
dc.indekslendigikaynak | Scopus | |
dc.indekslendigikaynak | PubMed | |
dc.language.iso | en | |
dc.publisher | Taylor & Francis Inc | |
dc.relation.ispartof | Ocular Immunology and Inflammation | |
dc.relation.publicationcategory | info:eu-repo/semantics/openAccess | |
dc.rights | info:eu-repo/semantics/closedAccess | |
dc.snmz | KA_WoS_20250125 | |
dc.subject | Choroidal thickening | |
dc.subject | macular ganglion cell layer | |
dc.subject | psoriasis area and severity index | |
dc.subject | systemic inflammation | |
dc.subject | tumor necrosis factor alpha | |
dc.title | Evaluation of Macular Ganglion Cell-inner Plexiform Layer and Choroid in Psoriasis Patients Using Enhanced Depth Imaging Spectral Domain Optical Coherence Tomography | |
dc.type | Article |